|
| Titre : |
"PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT" |
| Type de document : |
document électronique |
| Auteurs : |
Ishak Kerrouche ; Goudjil, Lakhdar, Directeur de thèse |
| Editeur : |
Setif:UFA |
| Année de publication : |
2024 |
| Importance : |
1 vol (66 f .) |
| Format : |
29 cm |
| Langues : |
Anglais (eng) |
| Catégories : |
Thèses & Mémoires:Informatique
|
| Mots-clés : |
Inventory Management
Demand Forecasting
Counterfeit Medicines |
| Index. décimale : |
004 Informatique |
| Résumé : |
Effective management of inventory, demand, transportation, and quality is essential for achieving operational efficiency and maintaining product integrity within the pharmaceutical sector. This document examines fundamental principles such as cost reduction, demand forecasting, cold chain logistics, and quality control aimed at enhancing supply chain performance. A significant focus is placed on addressing the issue of counterfeit medications through the implementation of Good Supply Chain Practices (GSCP) and advanced traceability technologies. For platforms like “PharmaConnect,” these strategies are critical for fostering collaboration among pharmacies, manufacturers, and distributors, ensuring the prompt delivery of genuine medicines, and upholding regulatory standards. By utilizing innovative solutions and strong management practices, “PharmaConnect” contributes to public health and improves industry efficiency. |
| Note de contenu : |
Sommaire
GENERAL INTRODUCTION………………………………………………………..…1
Theoretical part
Chapter I. Stock management
I.1. Introduction……………………………………………………………………...……3
I.2. Definition of stock management………………………………….……...…...4
I.3. Principles of stock management………………………………………………..…5
I.4. Stock management methods………………………………………………………………5
I.4.1. FIFO method (First in, First Out)……………….…………………………………6
I.4.2. LIFO Method (Last in, First Out)………………………………………………….6
I.4.3. Weighted average cost method………………………………..…………………...6
I.4.4. ABC analysis………………………………………………………………….…...7
I.4.5. Computerized inventory management systems……………….……………….…..7
I.5. Optimization of stock levels…………………………………………..……………….…..9
I.6. Management of pharmaceutical products………….………………...……….…11
I.6.1. Temperature control………………………………….…...………………………11
I.6.2. Management of expiration dates……………………………………………….…11
I.6.3. Regulatory conformity…………………………………….…...………………....11
I.6.4. Product traceability………………………………………….……………………11
I.6.5. Orders and supplies management………………………….……………………..11
I.6.6. Security and confidentiality…………………………………..…………………..12
I.7. Conclusion ……………………………………………………………………………..….13
Chapter II. Demand planning
II.1.Introduction………………………………………………………………….…………...14
II.2. Definition of demand planning………………..………………………..……….15
II.3. Forecasting of the demand for drugs……………………..………….…….……16
II.34 Factors influencing the demand for drugs…………………….……….……….17
II.4.1. Demography……………………………………………………………………..17
II.4.2. Epidemiology and Public Health……………………………….………………..18
II.4.3. Medical and technological advances……………………..……….…….……….18
II.4.4. Health policies and regulations .…………………………………...……………18
II.4.5. Consumer behavior and health professionals……………………….………….18
II.5. demand planning methods………………………………………….….………19
II.5.1. Quantitative forecasts……………………..…………...……………………….19
II.5.2. Qualitative Forecasting…………………….……………………….…………. 21
II.6. Demand Management Strategies……………………………..…………….………….22
II.7. Conclusion…………………………………………………………..……….…………..24
Chapter III. Transport and Logistics
III.1. Introduction…………………………………………………………….…………..…..25
III.2. Definition of Transportation and Logistics………………………………...….26
III.3. Transportation of Pharmaceuticals……………………………….........……..26
III.4. Cold Chain Requirements…………………………...…………………………………28
III.5. Pharmaceutical Logistics……………………………………………...………..29
III.6. Safety Stock Management………………………………………………………30
III.7. Conclusion…………………………………………………………………..…………………32
Chapter IV. Quality Management
IV.1. Introduction…………………………………………………………..………………....33
IV.2. Definition of Quality Management …………………………………………… 34
IV.3. Good Manufacturing Practices (GMP) …………………..………..…………35
IV.4. Good Distribution Practices (GDP)…………………………………….………36
IV.5. Quality Management System (QMS)…………………..………….…………..38
IV.6. Quality control of medicinal products…………………………………...……..41
IV.7. Conclusion…………………………………………………………………..…….……..43
Chapter V. Fight against counterfeiting
V.1. Introduction…………………………………………………….……….………………..44
V.2. Definition of anti-counterfeiting……………………………………….………...45
V.3. Anti-counterfeiting efforts…………………………………………..…..……….45
V.4. Scope of the problem of counterfeit medicines………..………..………………46
V.5. Risks Associated with Counterfeit Medicines……………...….………………..47
V.6. Anti-counterfeiting strategies……………………………………………………48
V.7. Role of GSCP in the fight against counterfeiting…………….……..………….50
V.8. Conclusion………………………………………………………………………...……...52
Chapter VI. PRACTICAL PART
PharmaConnect Technical Specifications…………………………..……………………….53
VI.1. Overview………………………………………………………………………...53
VI.2.1. Technologies…………………………………………………………………...53
VI.2.2. Features……………………………………………………………...…………53
VI.3. Frontend…………………………………………………………………………54
VI.3.1. Technologies………………………………………………..………….………54
VI.3.2. Features……………………………………………………...…………………54
VI.4. Security…………………………………………………………………………..54
VI.4.1. Authentication and Authorization………………………...……………………54
VI.5. Documentation…….......………………………………………………………..55
VI.5.1. API Documentation………………..........................………………………………..55
the start-up projects
FIRST AXIS Presentation of the start-up project
I. Presentation of the project………………………………………………….………………56
I.1. The project idea (proposed solution)…………………………………….…………56
I.2. The proposed values…………………………………………………………...……56
I.3. Teamwork ……………………………………...…..…………………………….....57
I.4. The project’s objectives………………………………..……………..……………..57
I.5. Completion schedule…………………………………….……………..……………58
SECOND AXIS Innovative aspects
II. Innovative aspects………………………………………….…………………………….59
II.1. The nature of the innovation……….…………………..……………………59
II.2. The field of innovation…………………..…………………..………………..59
THIRD AXIS Strategic market analysis
III. Strategic market analysis…………………………….…...……………………………60
III.1. The market segments………………………….………………..…….……..60
III.2. The intensity of competition for this project..……………………………..60
III.3. Project marketing strategy………………………….………………………61
FOURTH AXIS Production and Organization plan
IV. Production and organization plan………………….……………………..……………….62
IV.1. Procurement……………………………………….………………..…………………62
IV.2. Workforce (employees)………………………………..………….…………………..62
IV.3. The Main Partners……………………………………..………..…..………………62
FIFTH AXIS Financial plan
V. Financial Plan………………………………………………….……..…………………..64
V.1. Costs and expenses………………………………………………..……………………64 |
| Côte titre : |
MAI/0960 |
"PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT" [document électronique] / Ishak Kerrouche ; Goudjil, Lakhdar, Directeur de thèse . - [S.l.] : Setif:UFA, 2024 . - 1 vol (66 f .) ; 29 cm. Langues : Anglais ( eng)
| Catégories : |
Thèses & Mémoires:Informatique
|
| Mots-clés : |
Inventory Management
Demand Forecasting
Counterfeit Medicines |
| Index. décimale : |
004 Informatique |
| Résumé : |
Effective management of inventory, demand, transportation, and quality is essential for achieving operational efficiency and maintaining product integrity within the pharmaceutical sector. This document examines fundamental principles such as cost reduction, demand forecasting, cold chain logistics, and quality control aimed at enhancing supply chain performance. A significant focus is placed on addressing the issue of counterfeit medications through the implementation of Good Supply Chain Practices (GSCP) and advanced traceability technologies. For platforms like “PharmaConnect,” these strategies are critical for fostering collaboration among pharmacies, manufacturers, and distributors, ensuring the prompt delivery of genuine medicines, and upholding regulatory standards. By utilizing innovative solutions and strong management practices, “PharmaConnect” contributes to public health and improves industry efficiency. |
| Note de contenu : |
Sommaire
GENERAL INTRODUCTION………………………………………………………..…1
Theoretical part
Chapter I. Stock management
I.1. Introduction……………………………………………………………………...……3
I.2. Definition of stock management………………………………….……...…...4
I.3. Principles of stock management………………………………………………..…5
I.4. Stock management methods………………………………………………………………5
I.4.1. FIFO method (First in, First Out)……………….…………………………………6
I.4.2. LIFO Method (Last in, First Out)………………………………………………….6
I.4.3. Weighted average cost method………………………………..…………………...6
I.4.4. ABC analysis………………………………………………………………….…...7
I.4.5. Computerized inventory management systems……………….……………….…..7
I.5. Optimization of stock levels…………………………………………..……………….…..9
I.6. Management of pharmaceutical products………….………………...……….…11
I.6.1. Temperature control………………………………….…...………………………11
I.6.2. Management of expiration dates……………………………………………….…11
I.6.3. Regulatory conformity…………………………………….…...………………....11
I.6.4. Product traceability………………………………………….……………………11
I.6.5. Orders and supplies management………………………….……………………..11
I.6.6. Security and confidentiality…………………………………..…………………..12
I.7. Conclusion ……………………………………………………………………………..….13
Chapter II. Demand planning
II.1.Introduction………………………………………………………………….…………...14
II.2. Definition of demand planning………………..………………………..……….15
II.3. Forecasting of the demand for drugs……………………..………….…….……16
II.34 Factors influencing the demand for drugs…………………….……….……….17
II.4.1. Demography……………………………………………………………………..17
II.4.2. Epidemiology and Public Health……………………………….………………..18
II.4.3. Medical and technological advances……………………..……….…….……….18
II.4.4. Health policies and regulations .…………………………………...……………18
II.4.5. Consumer behavior and health professionals……………………….………….18
II.5. demand planning methods………………………………………….….………19
II.5.1. Quantitative forecasts……………………..…………...……………………….19
II.5.2. Qualitative Forecasting…………………….……………………….…………. 21
II.6. Demand Management Strategies……………………………..…………….………….22
II.7. Conclusion…………………………………………………………..……….…………..24
Chapter III. Transport and Logistics
III.1. Introduction…………………………………………………………….…………..…..25
III.2. Definition of Transportation and Logistics………………………………...….26
III.3. Transportation of Pharmaceuticals……………………………….........……..26
III.4. Cold Chain Requirements…………………………...…………………………………28
III.5. Pharmaceutical Logistics……………………………………………...………..29
III.6. Safety Stock Management………………………………………………………30
III.7. Conclusion…………………………………………………………………..…………………32
Chapter IV. Quality Management
IV.1. Introduction…………………………………………………………..………………....33
IV.2. Definition of Quality Management …………………………………………… 34
IV.3. Good Manufacturing Practices (GMP) …………………..………..…………35
IV.4. Good Distribution Practices (GDP)…………………………………….………36
IV.5. Quality Management System (QMS)…………………..………….…………..38
IV.6. Quality control of medicinal products…………………………………...……..41
IV.7. Conclusion…………………………………………………………………..…….……..43
Chapter V. Fight against counterfeiting
V.1. Introduction…………………………………………………….……….………………..44
V.2. Definition of anti-counterfeiting……………………………………….………...45
V.3. Anti-counterfeiting efforts…………………………………………..…..……….45
V.4. Scope of the problem of counterfeit medicines………..………..………………46
V.5. Risks Associated with Counterfeit Medicines……………...….………………..47
V.6. Anti-counterfeiting strategies……………………………………………………48
V.7. Role of GSCP in the fight against counterfeiting…………….……..………….50
V.8. Conclusion………………………………………………………………………...……...52
Chapter VI. PRACTICAL PART
PharmaConnect Technical Specifications…………………………..……………………….53
VI.1. Overview………………………………………………………………………...53
VI.2.1. Technologies…………………………………………………………………...53
VI.2.2. Features……………………………………………………………...…………53
VI.3. Frontend…………………………………………………………………………54
VI.3.1. Technologies………………………………………………..………….………54
VI.3.2. Features……………………………………………………...…………………54
VI.4. Security…………………………………………………………………………..54
VI.4.1. Authentication and Authorization………………………...……………………54
VI.5. Documentation…….......………………………………………………………..55
VI.5.1. API Documentation………………..........................………………………………..55
the start-up projects
FIRST AXIS Presentation of the start-up project
I. Presentation of the project………………………………………………….………………56
I.1. The project idea (proposed solution)…………………………………….…………56
I.2. The proposed values…………………………………………………………...……56
I.3. Teamwork ……………………………………...…..…………………………….....57
I.4. The project’s objectives………………………………..……………..……………..57
I.5. Completion schedule…………………………………….……………..……………58
SECOND AXIS Innovative aspects
II. Innovative aspects………………………………………….…………………………….59
II.1. The nature of the innovation……….…………………..……………………59
II.2. The field of innovation…………………..…………………..………………..59
THIRD AXIS Strategic market analysis
III. Strategic market analysis…………………………….…...……………………………60
III.1. The market segments………………………….………………..…….……..60
III.2. The intensity of competition for this project..……………………………..60
III.3. Project marketing strategy………………………….………………………61
FOURTH AXIS Production and Organization plan
IV. Production and organization plan………………….……………………..……………….62
IV.1. Procurement……………………………………….………………..…………………62
IV.2. Workforce (employees)………………………………..………….…………………..62
IV.3. The Main Partners……………………………………..………..…..………………62
FIFTH AXIS Financial plan
V. Financial Plan………………………………………………….……..…………………..64
V.1. Costs and expenses………………………………………………..……………………64 |
| Côte titre : |
MAI/0960 |
|
Ajouter le résultat dans votre panier Affiner la recherche
